Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Humana's Marketable Securities for the quarter that ended in Jun. 2026 was MXN296,249 Mil.
Humana's annual Marketable Securities
increased
from Dec. 2023 (MXN282,214 Mil) to Dec. 2024 (MXN379,866 Mil) but then
declined
from Dec. 2024 (MXN379,866 Mil) to Dec. 2025 (MXN282,744 Mil).
Humana (MEX:HUM) Marketable Securities Explanation
Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".
Humana Marketable Securities Related Terms
Humana Marketable Securities Historical Data
* Premium members only.
The historical data trend for Humana's Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Marketable Securities of MXN296,249 Mil mean?
Humana (MEX:HUM) has a Marketable Securities of MXN296,249 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Humana and its competitors.
Is Humana's Marketable Securities too high?
Humana's current Marketable Securities is MXN296,249 Mil. Overall, Humana has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Humana's Marketable Securities compare to CNC and CI?
Humana's Marketable Securities of MXN296,249 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Plans company?
A good Marketable Securities depends on the Healthcare Plans industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Humana and its competitors. Humana's current Marketable Securities is MXN296,249 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana stock overvalued right now?
Based on GuruFocus' analysis, Humana (MEX:HUM) is currently considered Fairly Valued. The stock's GF Value™ is MXN6,807.03, compared to a current price of MXN6,766.67 — trading 0.6% below its estimated fair value. The current Marketable Securities is MXN296,249 Mil. Humana's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Humana (MEX:HUM), the current Marketable Securities is MXN296,249 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humana (MEX:HUM) Overvalued in 2026?
Based on GuruFocus' analysis, Humana stock appears to be undervalued.
The current stock price of MXN6,766.67 is trading 0.6% below its estimated GF Value™ of MXN6,807.03.
GuruFocus considers Humana to be Fairly Valued.
Key valuation signals for MEX:HUM:
Marketable Securities: MXN296,249 Mil
GF Value™: MXN6,807.03 vs. price of MXN6,766.67 (0.6% below fair value)
No single metric tells the full story. See the MEX:HUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
82GF Score
Get the complete analysis for MEX:HUM
Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:HUM has been successfully added to your 
